ES2066768T3 - Agentes de contraste en la formacion de imagenes por resonancia magnetica nuclear del tipo dipiridoxil-fosfato. - Google Patents

Agentes de contraste en la formacion de imagenes por resonancia magnetica nuclear del tipo dipiridoxil-fosfato.

Info

Publication number
ES2066768T3
ES2066768T3 ES88107346T ES88107346T ES2066768T3 ES 2066768 T3 ES2066768 T3 ES 2066768T3 ES 88107346 T ES88107346 T ES 88107346T ES 88107346 T ES88107346 T ES 88107346T ES 2066768 T3 ES2066768 T3 ES 2066768T3
Authority
ES
Spain
Prior art keywords
contrast agents
phosphate
dipiridoxil
formation
magnetic resonance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88107346T
Other languages
English (en)
Inventor
Scott M Rocklage
Steven C Quay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amersham Health Salutar Inc
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Application granted granted Critical
Publication of ES2066768T3 publication Critical patent/ES2066768T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Public Health (AREA)
  • Signal Processing (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LOS ACIDOS N,N''-BIS-(PIRIDOXAL-5-FOSFATO)-ALQUILENDIAMINA-N, N''-DIACETICOS, N, N''-BIS-(PIRIDOXAL-5-FOSFATO)-1,2CICLOALQUILENDIAMINA-N,N''-DIACETICO, Y N, N''-BIS (PIRIDOXAL-5-FOSFATO)-1,2-ARILENDIAMINA-N,N''-DIACETICO, LOS CORRESPONDIENTES COMPUESTOS DE MONOFOSFATO Y DE LOS ACIDOS MONOACETICOS, ASI COMO SUS SALES Y ESTERES FORMAN QUELATOS ESTABLES MUY SOLUBLES CON IONES METALICOS PARAMAGNETICOS, Y SON AGENTES DE CONTRASTE RAIOLOGICO PARA RMN ALTAMENTE EFICACES. LOS AGENTES DE CONTRASTE PREFERIDO SON LOS YA CITADOS DE ACIDOS DIACETICOS Y SUS SALES CALCICAS SOLUBLES. LA INVENCION SE REFIERE TAMBIEN A NUEVOS COMPUESTOS INTERMEDIOS PARA FORMAR ESTOS COMPUESTOS.
ES88107346T 1987-05-08 1988-05-06 Agentes de contraste en la formacion de imagenes por resonancia magnetica nuclear del tipo dipiridoxil-fosfato. Expired - Lifetime ES2066768T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/047,614 US4933456A (en) 1987-05-08 1987-05-08 Dipyridoxyl phosphate NMRI contrast agents

Publications (1)

Publication Number Publication Date
ES2066768T3 true ES2066768T3 (es) 1995-03-16

Family

ID=21949962

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88107346T Expired - Lifetime ES2066768T3 (es) 1987-05-08 1988-05-06 Agentes de contraste en la formacion de imagenes por resonancia magnetica nuclear del tipo dipiridoxil-fosfato.

Country Status (20)

Country Link
US (1) US4933456A (es)
EP (1) EP0290047B1 (es)
JP (1) JP2512524B2 (es)
AR (1) AR246956A1 (es)
AT (1) ATE118010T1 (es)
AU (1) AU613363B2 (es)
BR (1) BR1100623A (es)
CA (1) CA1322003C (es)
DE (2) DE3852906T2 (es)
DK (1) DK173849B1 (es)
ES (1) ES2066768T3 (es)
FI (1) FI88164C (es)
GR (1) GR3015884T3 (es)
HK (1) HK55195A (es)
IE (1) IE66368B1 (es)
IL (1) IL86298A (es)
NL (1) NL970040I2 (es)
NO (2) NO177462C (es)
NZ (1) NZ224537A (es)
SG (1) SG30569G (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422096A (en) * 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US4994259A (en) * 1987-05-08 1991-02-19 Salutar, Inc. Improvement in the method of NMR imaging employing a manganese II chelates of N,N'-bis[pyridoxal-alkylene (or cycloalkylene) (or arylene)]-N,N'-diacetic acid derivatives
US4827426A (en) * 1987-05-18 1989-05-02 The Coca-Cola Company Data acquisition and processing system for post-mix beverage dispensers
US5087440A (en) * 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
AU7346091A (en) * 1990-03-02 1991-09-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Preparations for mr diagnosis
AU8325491A (en) * 1990-08-15 1992-03-17 Byk Gulden Lomberg Chemische Fabrik Gmbh New use of complex salts
DE4026103A1 (de) * 1990-08-17 1992-02-20 Byk Gulden Lomberg Chem Fab Neue verwendung von komplexsalzen
WO1992011840A1 (de) * 1991-01-07 1992-07-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Kontrastmittel für die mr-diagnostik
DE4107570A1 (de) * 1991-03-07 1992-11-19 Diagnostikforschung Inst Chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie
JPH06507904A (ja) * 1991-05-23 1994-09-08 イマアーレクス・フアーマシユーチカル・コーポレーシヨン 磁気共鳴画像形成用の油脂可溶化合物
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
TW319763B (es) 1995-02-01 1997-11-11 Epix Medical Inc
SG81898A1 (en) * 1995-08-11 2001-07-24 Sumitomo Chemical Co Olefin polymerization catalyst component, olefin polymerization catalyst and process for producing olefin polymer
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
ES2297888T3 (es) * 1997-07-01 2008-05-01 Ge Healthcare As Procedimiento diagnostico para la deteccion de isquemia miocardica.
AU1770299A (en) * 1997-12-23 1999-07-19 Nycomed Imaging As Nitric oxide releasing chelating agents and their therapeutic use
FR2867473B1 (fr) 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
US9187509B2 (en) * 2012-01-05 2015-11-17 Pled Pharma AB Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632637A (en) * 1968-02-13 1972-01-04 Arthur E Martell Hydroxyaryl-containing aminocarboxylic chelating agents
AU485693B2 (en) * 1973-08-24 1976-02-05 The Council Ofthe Institute Of Medical And Veterinary Science, Andthe Universityof Adelaide Gariti Cancer Foundation New radiopharmaceuticals for cholescintigraphy
JPS5569517A (en) * 1978-11-20 1980-05-26 Nippon Mejifuijitsukusu Kk Labelling preparation for labelling of erythrocytes with radio-active technetium
JPS5791927A (en) * 1980-11-27 1982-06-08 Nippon Mejifuijitsukusu Kk Technetium-99m labelled diagnosticum
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
JPS5896031A (ja) * 1981-12-03 1983-06-07 Nippon Mejifuijitsukusu Kk 放射性診断剤およびその製造用組成物
US4637929A (en) * 1985-01-04 1987-01-20 Salutar, Inc. Ferrioxamine-paramagnetic contrast agents for MR imaging, composition, apparatus and use
US4842845A (en) * 1987-05-08 1989-06-27 Salutar, Inc. Radioactive metal chelates for dipyridoxyl phosphate
US4935518A (en) 1987-05-08 1990-06-19 Salutar, Inc. Manganese(II), chelate contrast agents derived from N,N'-bis-(pyridoxal ethylene diamine-N,N')-diacetic acid and derivatives thereof

Also Published As

Publication number Publication date
AR246956A1 (es) 1994-10-31
DE19775088I2 (de) 2001-05-23
DK251688D0 (da) 1988-05-06
CA1322003C (en) 1993-09-07
NO1998004I1 (no) 1998-01-19
IE881366L (en) 1988-11-08
DK251688A (da) 1988-11-09
NO882004D0 (no) 1988-05-06
FI882125A7 (fi) 1988-11-09
NL970040I1 (nl) 1998-02-02
AU1568088A (en) 1988-11-10
ATE118010T1 (de) 1995-02-15
IL86298A0 (en) 1988-11-15
JP2512524B2 (ja) 1996-07-03
NO882004L (no) 1988-11-09
EP0290047A3 (en) 1990-04-25
US4933456A (en) 1990-06-12
BR1100623A (pt) 1999-12-07
EP0290047B1 (en) 1995-02-01
GR3015884T3 (en) 1995-07-31
HK55195A (en) 1995-04-21
FI88164B (fi) 1992-12-31
EP0290047A2 (en) 1988-11-09
DK173849B1 (da) 2001-12-27
NO177462C (no) 1995-09-20
AU613363B2 (en) 1991-08-01
FI882125A0 (fi) 1988-05-06
NO177462B (no) 1995-06-12
IL86298A (en) 1992-11-15
NL970040I2 (nl) 1998-06-02
IE66368B1 (en) 1995-12-27
DE3852906D1 (de) 1995-03-16
JPS63280087A (ja) 1988-11-17
NZ224537A (en) 1991-06-25
FI88164C (fi) 1993-04-13
DE3852906T2 (de) 1995-06-22
SG30569G (en) 1995-09-18

Similar Documents

Publication Publication Date Title
ES2066768T3 (es) Agentes de contraste en la formacion de imagenes por resonancia magnetica nuclear del tipo dipiridoxil-fosfato.
ES504469A0 (es) Procedimiento para la preparacion de composiciones acuosas de sales polimericas de amonio cuaternario de base acrilica
ES504468A0 (es) Procedimiento para la preparacion de sales copolimericas de amonio cuaternatio de base acrilica
DE3853027D1 (de) Zwei-Frequenzen NMR Oberflächenspule.
ES8207156A1 (es) Procedimiento para la preparacion de nuevas pirimidinonas .
PL199019A1 (pl) Sposob wytwarzania nowych bis(3,5-dwukarbamoilo-2,4,6-trojjodoanilidow)kwasu dwukarboksylowego
IT1090625B (it) Procedimento per la fabbricazione di nuclei ferromagnetici per macchine dinamo-elettriche
ES2056105T3 (es) Di-t-butilfenoles sustituidos.
AR248140A1 (es) Composicion de 1, 4, 7, 10-tetraazaciclododecano como la fraccion macrolitica, o sales fisiologicamente aceptables del mismo y radionuclidos como agente terapeuticamente activo.
ES2061546T3 (es) Compuestos quelantes de piridoxamina, quelatos de manganeso (ii) y su uso como agentes de contraste de nmri.
ES473818A1 (es) Procedimiento para preparar derivados de piperazina.
BG27905A3 (bg) Метод за получаване на фосфонисти киселини
FR2398072A1 (fr) Acides et sels d'acides (n-carboxyalkyl-amino)-alcane-polyphosphoniques utilisables comme agents complexants
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES502018A0 (es) Un procedimiento para preparar una composicion detergente granular
ES2134409T3 (es) Formulaciones supresoras frente a las metastasis hepaticas de los tumores.
ATE1347T1 (de) Waesserige desinfektionsloesung.
ES2061530T3 (es) 9-amino-1,4-etano-1,2,3,4-tetrahidroacridina y compuestos afines, intermediarios y un procedimiento para la preparacion de los mismos y su uso como medicamentos.
ES2095848T3 (es) Nuevos derivados de fosfolipidos y su utilizacion para la preparacion de medicamentos antiviricos.
TNSN90153A1 (fr) Procede de preparation de derives du glycerol
FR2376150A1 (fr) Compositions therapeutiques a base de derives de l'hexahydro-1,2,3,3a,4,5-canthine
ES8702385A1 (es) Un procedimiento para preparar un compuesto heterociclico nitrogenado
ES2053590T3 (es) 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados.
BG30928A3 (en) Method for obtaining of 2- /3- aryl- 5- isoxazolin benzoic acids
ATE44231T1 (de) Haarbehandlungsmittel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 290047

Country of ref document: ES

SPCF Request for supplementary protection certificate filed

Free format text: REGISTRY NO/DATE: 668442 19980113, FIRST REGISTRY NO/DATE: UEEU/1/97/040/001 19970522

Spc suppl protection certif: C9800022

Filing date: 19980713

SPCG Supplementary protection certificate granted

Free format text: PRODUCT NAME: MANGAFODIPIR (TELASCAN), REGISTRY NO/DATE: 668442 19980113, FIRST REGISTRY NO/DATE: UEEU/1/97/040/001 19970522

Spc suppl protection certif: C9800022

Filing date: 19980713